Haleon Agrees to Sell ChapStick Brand for Up to $510 Million
By Michael Susin
Haleon said that it has agreed to sell ChapStick lip-care brand to Suave Brands Co. for up to $510 million as it seeks to divest from non-core assets and reduce debt.
The consumer-healthcare business--which was spun out of GSK and is partly owned by Pfizer--said on Thursday it will receive cash proceeds of around $430 million, as well as a passive minority interest in the Suave Brands Co.--a portfolio company of private-equity firm Yellow Wood Partners--valued at up to $80 million.
Haleon said proceeds from the sale will be used to pay down debt.
"[ChapStick] is not a core focus for Haleon. Selling the brand allows us to simplify our business and pay down debt more quickly," Chief Executive Brian McNamara said.
The sale is expected to close in the second quarter of 2024.
Write to Michael Susin at michael.susin@wsj.com
(END) Dow Jones Newswires
January 25, 2024 02:38 ET (07:38 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening In the Markets This Week
-
Can the Fed Declare Victory on Inflation?
-
After Earnings, Is Coinbase Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Albemarle Stock a Buy, a Sell, or Fairly Valued?
-
Is ServiceNow Stock a Buy After Earnings and Its Investor Day?
-
3 Stocks to Buy and 3 Stocks to Sell After Earnings
-
Today’s Market Volatility Could Provide Tomorrow’s Opportunities
-
40 of the Best Investment Picks
-
Tech Stock Dividends Are Changing the Face of Dividend Growth Investing
-
Roblox Earnings: Weakening Engagement Has Weighed On Growth
-
The Best Gaming Stocks to Buy
-
Energy Transfer Earnings: M&A Drives Guidance Increase In Solid Quarter
-
The Best Healthcare Stocks to Buy
-
Going Into Earnings, Is Home Depot Stock a Buy, a Sell, or Fairly Valued?